This is not the most recent version of the article. View current version (8 DEC 2010)
Intervention Protocol
Hyperfractionated and/or accelerated radiotherapy versus conventional radiotherapy for head and neck cancer
Editorial Group: Cochrane Ear, Nose and Throat Disorders Group
Published Online: 21 JAN 2009
DOI: 10.1002/14651858.CD002026
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Database Title
Additional Information
How to Cite
Pignon JP, Sylvester R, Bourhis J. Hyperfractionated and/or accelerated radiotherapy versus conventional radiotherapy for head and neck cancer (Protocol). Cochrane Database of Systematic Reviews 2000, Issue 2. Art. No.: CD002026. DOI: 10.1002/14651858.CD002026.
Publication History
- Publication Status: Edited (no change to conclusions)
- Published Online: 21 JAN 2009
This is not the most recent version of the article.View current version (08 Dec 2010)
Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows:
Assessment of the role of modified fractionated radiotherapy in head and neck squamous carcinoma by studying the following questions:
Main objective
To assess the effect of modified fractionated radiotherapy on the survival of patients with HNSCC by comparing conventional radiotherapy with hyperfractionated and / or accelerated radiotherapy.
Secondary objectives
To investigate the interaction between the treatment effect and the type of radiotherapy (indirect comparison) and to investigate the interaction between the treatment effect and the prognostic factors (subgroup analysis).
